Cancer 1991: Vol 67 Index

35 Pages·1991·8.6 MB·English

Subject Index—Volume 67
January |, pp. 1-214 No. 6, March 15, Supplement, pp. 1715-1824
January 1, Supplement, pp. 215-330 No. 7, April 1, pp. 1825-2020
January 15, pp. 331-546 No. 8, April 15, pp. 2021-2224
February 1, pp. 547-764 No. 9 May |, pp. 2225-2418
February 1, Supplement, pp. 765-868 No. 10, May 15, pp. 2419-2680
February 15, pp. 869-1118 No. 10, May 15, Supplement, pp. 2681-2730
February 15, Supplement, pp. 1119-1284 No. 11, June 1, pp. 2731-2948
March 1, pp. 1285-1470 No. 12, June 15, pp. 2949-3200
March 15, pp. 1471-1714
A Adrenal carcinoma
5-fluorouracil, doxorubicin, and cisplatin for, 2997
ABH(O) antigens
simulating cutaneous angiosarcoma, 2766
in bladder intraepithelial dysplasia and transitional cell car-
staging of, 1199
cinoma, 1661
Adrenoceptor density, in hepatocellular carcinoma, 2543
in esophageal carcinoma, 3042
Adrenocorticotropic hormone. See Ectopic adrenocorticotropic
ABO(H) antigens, in transitional cell carcinoma of bladder, 3024
hormone syndrome
Abortion, early, breast cancer proliferation and DNA ploidy
Adriamycin. See Doxorubicin
and, 1285
Adult T-cell leukemia, Ki-67-positive cells in, prognosis and,
Acinic cell carcinoma, prognostic factors in, 172
2605
Aclacinomycin, in acute leukemia, with etoposide, 281, 285
Adult T-cell leukemia-lymphoma, with Hodgkin’s disease-like
Acoustic neurinoma, radiosurgery of, 345
histologic features, 1622
Acquired immunodeficiency syndrome
AE1 and AE3 monoclonal antibodies, in pleural mesothelioma
disseminated leiomyosarcoma in, in child, 2618
differentiation, 655
primary central nervous system lymphoma in, 2756
African-Americans, metastatic breast cancer outcome in, vs. in
ACTH. See Ectopic adrenocorticotropic hormone syndrome
whites, 2850
Actinomycin D, single vs. fractionated, in Wilms’ tumor, 2990
Age. See also Children; Elderly
Acute leukemia. See Leukemia, acute
and breast cancer survival, 2227
Acute respiratory failure, in leukemia, 696
and hepatocellular carcinoma growth mode, 2626
Adenine nucleotide pools, in human peripheral leukocytes, hy-
and prostate cancer treatment, 2633
perthermic effects on, 2096
AHBuBP bisphosphonate, osteolysis inhibition by, 643
Adenocarcinoma. See also sites of
AIDS. See Acquired immunodeficiency syndrome
bronchioloalveolar, with myoepithelial cells, 2356
Airway obstruction, life-threatening, Hodgkin’s disease pre-
clear cell, of vagina and cervix, 1971
senting as, 506
of endometrium
Alcohol
with clear cell carcinoma, cell lines from, 1588
pancreatic cancer and, 2664
isolated calcaneal metastasis in, 1979
tongue cancer and, in Uruguay, 180
in Norway, 3093 Aldolase isozymes, in lung cancer, 2153
gastric, carcinoembryonic antigen in, radiation effects on, 2269
Alfred P. Sloan, Jr., Prize, 2422
hepatoid, of renal pelvis, 3051
Alpha-1 and beta-2 adrenoceptor density, in hepatocellular car-
of lung
cinoma, 2543
metastases in, cytofluometric analysis of, 2941
Alpha class glutathione S-transferase, immunohistologic local-
pleural mesothelioma from, monoclonal antibody differ-
ization of, 1608
entiation of, 655
Alpha-fetoprotein
of pancreas, N-(phosphonacetyl)-L-aspartate and 5- fluoro-
glucosaminylation and fucosylation of, in liver neoplasia dif-
uracil for, 363
ferential diagnosis, 2390
of prostatic duct, 2118
from hepatoid adenocarcinoma of renal pelvis, 3051
serous papillary, of tunica vaginalis, 1450
lectin binding by, in hepatocellular carcinoma, 476
Adenoid cystic carcinoma, of esophagus, 2159
Alpha glutathione S-transferase, immunohistologic localization
Adenoma, depressed gastric, 2382
of, 1608
Adenosquamous carcinoma, of lung, clinicopathologic charac-
teristics of, 649 Alternative therapies, 1788, 2225
Adipose tissue distribution, breast cancer and, 523, 2215, 2622 Alveolar soft part sarcoma, vs. paraganglioma, 1894
Adolescents. See also Children American Cancer Society dietary guidelines, 2671
differentiated thyroid cancer in, 2186 American Cancer Society-National Prostate Cancer Detection
synovial sarcoma in, 1667 Project, detection of early stage disease and, 2949
Subject Index—Volume 67
January |, pp. 1-214 No. 6, March 15, Supplement, pp. 1715-1824
January 1, Supplement, pp. 215-330 No. 7, April 1, pp. 1825-2020
January 15, pp. 331-546 No. 8, April 15, pp. 2021-2224
February 1, pp. 547-764 No. 9 May |, pp. 2225-2418
February 1, Supplement, pp. 765-868 No. 10, May 15, pp. 2419-2680
February 15, pp. 869-1118 No. 10, May 15, Supplement, pp. 2681-2730
February 15, Supplement, pp. 1119-1284 No. 11, June 1, pp. 2731-2948
March 1, pp. 1285-1470 No. 12, June 15, pp. 2949-3200
March 15, pp. 1471-1714
A Adrenal carcinoma
5-fluorouracil, doxorubicin, and cisplatin for, 2997
ABH(O) antigens
simulating cutaneous angiosarcoma, 2766
in bladder intraepithelial dysplasia and transitional cell car-
staging of, 1199
cinoma, 1661
Adrenoceptor density, in hepatocellular carcinoma, 2543
in esophageal carcinoma, 3042
Adrenocorticotropic hormone. See Ectopic adrenocorticotropic
ABO(H) antigens, in transitional cell carcinoma of bladder, 3024
hormone syndrome
Abortion, early, breast cancer proliferation and DNA ploidy
Adriamycin. See Doxorubicin
and, 1285
Adult T-cell leukemia, Ki-67-positive cells in, prognosis and,
Acinic cell carcinoma, prognostic factors in, 172
2605
Aclacinomycin, in acute leukemia, with etoposide, 281, 285
Adult T-cell leukemia-lymphoma, with Hodgkin’s disease-like
Acoustic neurinoma, radiosurgery of, 345
histologic features, 1622
Acquired immunodeficiency syndrome
AE1 and AE3 monoclonal antibodies, in pleural mesothelioma
disseminated leiomyosarcoma in, in child, 2618
differentiation, 655
primary central nervous system lymphoma in, 2756
African-Americans, metastatic breast cancer outcome in, vs. in
ACTH. See Ectopic adrenocorticotropic hormone syndrome
whites, 2850
Actinomycin D, single vs. fractionated, in Wilms’ tumor, 2990
Age. See also Children; Elderly
Acute leukemia. See Leukemia, acute
and breast cancer survival, 2227
Acute respiratory failure, in leukemia, 696
and hepatocellular carcinoma growth mode, 2626
Adenine nucleotide pools, in human peripheral leukocytes, hy-
and prostate cancer treatment, 2633
perthermic effects on, 2096
AHBuBP bisphosphonate, osteolysis inhibition by, 643
Adenocarcinoma. See also sites of
AIDS. See Acquired immunodeficiency syndrome
bronchioloalveolar, with myoepithelial cells, 2356
Airway obstruction, life-threatening, Hodgkin’s disease pre-
clear cell, of vagina and cervix, 1971
senting as, 506
of endometrium
Alcohol
with clear cell carcinoma, cell lines from, 1588
pancreatic cancer and, 2664
isolated calcaneal metastasis in, 1979
tongue cancer and, in Uruguay, 180
in Norway, 3093 Aldolase isozymes, in lung cancer, 2153
gastric, carcinoembryonic antigen in, radiation effects on, 2269
Alfred P. Sloan, Jr., Prize, 2422
hepatoid, of renal pelvis, 3051
Alpha-1 and beta-2 adrenoceptor density, in hepatocellular car-
of lung
cinoma, 2543
metastases in, cytofluometric analysis of, 2941
Alpha class glutathione S-transferase, immunohistologic local-
pleural mesothelioma from, monoclonal antibody differ-
ization of, 1608
entiation of, 655
Alpha-fetoprotein
of pancreas, N-(phosphonacetyl)-L-aspartate and 5- fluoro-
glucosaminylation and fucosylation of, in liver neoplasia dif-
uracil for, 363
ferential diagnosis, 2390
of prostatic duct, 2118
from hepatoid adenocarcinoma of renal pelvis, 3051
serous papillary, of tunica vaginalis, 1450
lectin binding by, in hepatocellular carcinoma, 476
Adenoid cystic carcinoma, of esophagus, 2159
Alpha glutathione S-transferase, immunohistologic localization
Adenoma, depressed gastric, 2382
of, 1608
Adenosquamous carcinoma, of lung, clinicopathologic charac-
teristics of, 649 Alternative therapies, 1788, 2225
Adipose tissue distribution, breast cancer and, 523, 2215, 2622 Alveolar soft part sarcoma, vs. paraganglioma, 1894
Adolescents. See also Children American Cancer Society dietary guidelines, 2671
differentiated thyroid cancer in, 2186 American Cancer Society-National Prostate Cancer Detection
synovial sarcoma in, 1667 Project, detection of early stage disease and, 2949
No. 12 SUBJECT INDEX—VOLUME 67
American Indians, acute lymphocytic leukemia survival in, 2125 radiotherapy and, 412
American Joint Committee Stage staging system, for nasopha- in untreated prostate cancer, 2200
ryngeal carcinoma, 434 sialyl Lewis A, in digestive cancer, 1576
Amsacrine tumor-associated, in lymph nodes, immune responses to, in
in acute leukemia, with etoposide, 285 colon cancer, 2880
in acute lymphoblastic leukemia, 2235 Anti-keratin monoclonal antibody, in pleural mesothelioma dif-
Anal canal, squamous cell carcinoma of, 2038 ferentiation, 655
Anal carcinoma, chemotherapy and radiotherapy for, 2462 Anti-Leu-M1 mononoclonal antibody, in pleural mesothelioma
Analgesia, patient-controlled, 873 differentiation, 655
Anaplastic giant cell thyroid carcinoma, treatment of, 564 Anti-vimetin monoclonal antibody, in pleural mesothelioma
Androgen receptors differentiation, 655 5
in colon cancer, 1964 Aortic arch occlusion, by Aspergillus, after antileukemic che-
in laryngeal tumors, 1347 motherapy, 3123
in metastatic prostate cancer, 3057 Ara-C. See Cytosine arabinoside
Anemia Argyrophil small cell carcinoma of cervix, cell line from inte-
at Hodgkin’s disease diagnosis, prognosis and, 1389 grating HPV16 DNA, 2327
recombinant human erythropoietin in, 2708 Arterial embolization, transcatheter, in hepatocellular carci-
Angiography, digital subtraction, in parapharyngeal heman- noma, 81, 385
giopericytoma, 61 Arterial portography, computed tomography during, in liver
Angioimmunoblastic lymphoma, clinicopathology of, 2565 cancer, 1189
Angiosarcoma, cutaneous, adrenal carcinoma simulating, 2766 Asbestos, type and pulmonary concentration of, mesothelioma
Angiosarcomatosis, intra-abdominal, after pelvic radiotherapy, risk and, 1912
2275 Asian Americans, increasing numbers of, cancer care and, 1773
Angiotropic lymphoma, congenital, 2131 Aspergillus, aortic arch occlusion by, after antileukemic che-
Anthracyclines, in childhood cancer, osteosarcoma after, 193 motherapy, 3123
Antibodies Aspiration, ultrasound-guided, of ovarian tumors, 1326
in estrogen receptor localization, in gastric cancer, 2401 Aspiration biopsy
HBA-71, in Ewing’s sarcoma and peripheral primitive neu- of bone tumors, 1169
roectodermal tumors, 1886 of breast cancer, for oncogene analaysis, 1396
against interferon-beta but not interferon-gamma, in mela- of cold thyroid nodules, 2137
noma, 2300 of hepatocellular carcinoma, 673
MIC2, in Ewing’s sarcoma and peripheral primitive nevroec- of lymph nodes, vs. excisional biopsy, 1003
todermal tumors, 1886 of lymphoproliferative lesions, in HIV-positive patients, 1008
monoclonal, in estrogen receptor localization, in gastric cancer, of occult breast lesions, with scouting needle, 2150
2401 in pancreatic duct stenosis, 2395
neutralizing, to interleukin-2, 1862 ultrasound guided, in esophageal cancer, 585
in pleural mesothelioma differentiation, 655 Astrocytic tumors, adult cerebral, bromodeoxyuridine- labeling
RNL-1, 2, 3, to neuroendocrine antigens, 619 indices and prognosis in, 1629
Antibody fluorescein conjugates, for photodiagnosis of colon Astrocytoma
cancer, 2529 cerebellar, histologic condition and treatment of, in children,
Anti-CEA monoclonal antibody, in pleural mesothelioma dif- 2772
ferentiation, 655 high-grade, accelerated fractionation for, 2247
Antierythrocyte autoantibody formation, after interleukin-2 and intracarotid chemotherapy for, 2844
gamma-interferon, 2512 Autoimmune toxicity, of interleukin-2 and interferon- gamma,
Antigen(s) 2512
blood group
in bladder intraepithelial dysplasia, 1661
in esophageal carcinoma, 3042 B
in transitional cell carcinoma of bladder, 3024, 1661
carcinoembryonic, in gastric adenocarcinoma cells, radiation Bacillus Calmette-Guerin therapy, in transitional cell carcinoma
effects on, 2269 of bladder, ABO(H) antigens and beta-2 microgiobulin
CD34, in Philadelphia chromosome-positive acute lympho- and, 3024
blastic leukemia, 1565 Bacteremia
H, in squamous cell carcinoma, 613 clostridial, 1928
human leukocyte, in thyroid tumors, 977 staphylococcal, interleukin-2 therapy and, 1570
Ki-67, in breast tumors Barium enema, guidelines for, 1150
phenotypic differentiation and, 463 Basement membrane deposition, in squamous cell carcinoma
prognosis and, 421 of lung, prognosis and, 3001
Lewis X, as Reed-Sternberg cell marker, 1338 B-cell lymphoma
myeloid, in acute lymphoid leukemia, 3081 extragonadal monocytoid, 2305
neuroendocrine, 619 primary anterior mediastinal, 2579
proliferative-associated p105, in gastric carcinoma, 2523 primary cutaneous, 2311
prostate-specific BCG therapy, in transitional cell carcinoma of bladder, ABO(H)
prognosis and, 3014 antigens and beta-2 microglobulin and, 3024
3168 CANCER June 15 1991 Vol. 67
Behavioral changes B.72.3 mononoclonal antibody, in pleural mesothelioma differ-
assessment of, 805 entiation, 655
for cancer prevention Body fat distribution, breast cancer and, 523, 2215, 2622
assessment of, 805 Bone
epidemiologic perspectives on, 808 leiomyosarcoma of, 1051
Behavioral research resorption of, bisphosphonate AHBuBP inhibition of, 643
current status of and future priorities for, 767, 865 sarcoma of. See Osteosarcoma
for prevention and early detection, 800 tumors of, imaging of, 1169
Bence Jones multiple myeloma, meningeal involvement in, 1900 Ene marrow, breast cancer cells in, detection of, 1033
Benign neoplasm, intratumoral cytogenetic heterogeneity in, Boue marrow relapse, in acute lymphoid leukemia, 37
3110 Bone marrow transplantation
Benzylguanidine, in neuroblastoma, 922 in chronic myelogenous leukemia, reappearance of Ph- neg-
Beta-2 and alpha-1 adrenoceptor density, in hepatocellular car- ative cells after, 2959
cinoma, 2543 etoposide and, 292
Beta-carotene, cellular immunity and, 1556 late renal dysfunction in, 2795
Beta-human chorionic gonadotropin-positive extragonadal germ Bone scan, in early breast cancer follow-up, 55
cell neoplasia, of renal pelvis, 3146 Brachytherapy. See also Radiotherapy
Biopsy in desmoid tumor, with surgery, 380
of bone tumors, 1169 gynecologic, perioperative morbidity and mortality with, 2786
excisional, of lymph nodes, vs. aspiration biopsy, 1003 Brain. See also under Central nervous system
fiberoptic, in nasopharyngeal cancer diagnosis, 3127 Hodgkin’s disease of, and HIV infection, 2931
fine-needle aspiration metastases to, as first symptom in bronchogenic carcinoma,
in breast cancer, for oncogene analysis, 1396 2935
of cold thyroid noduies, 2137 non-Hodgkin’s lymphoma of
vs. excisional, of lymph nodes, 1003 in AIDS, 2756
of hepatocellular carcinoma, 673 Epstein-Barr virus in. in situ hybridization of, 2756
of lymph nodes, vs. excisional biopsy, 1003 after Hodgkin’s disease, 441
of lymphoproliferative lesions, in HIV-positive patients, as second malignancy, 1431
i008 tumors of
of occult breast lesions, with scouting needle, 2150 accelerated fractionation radiotherapy for, 2247
in pancreatic duct stenosis, 2395 adult astrocytic, bromodeoxyuridine-labeling indices and
ultrasound-guided prognosis in, 1629
in esophageal carcinoma, 585 imaging of, 1278
of ovarian tumors, 1326 in children, 1223
of liver tumors, 1189 intracarotid etoposide and cisplatin for, 2844
of lung tumors, fiberoptic bronchoscopy for, 72 Brain stem glioma, carboplatin for, 43
Blacks, metastatic breast cancer outcome in, vs. in whites, 2850 Breast, mammography for
Black tobacco, bladder cancer and, in Uruguay, 536 in early breast cancer follow-up, 55
Bladder patient selection for, 2010
adenocarcinoma of, clinicopathology of, 2165 routine, in detection of asynchronous contralateral breast
carcinoma of cancer, 1844
epidemiology of, in U.S. vs. Japan, 746 treatment reults after detection by, 2801
human leukocyte antigen II, interleukin-6, and interleukin- Breast cancer
6 receptor expression in, 2087 adjuvant therapy for, weight gain with, 1954
prognostic factors in, 1525 advanced, stanozolol for, 2966
risk factors for, in Uruguay, 536 asynchronous contralateral, early detection of, by routine
intraepithelial dysplasia of, ABH(O) blood group antigens in, mammography, i844
1661 body fat distribution and, 523, 2215, 2622
transitional cell carcinoma of bone marrow micrometastasis in, detection of, 1033
ABH(O) antigens in, 1661 c-erbB2/neu expression in, 2142
ABO(H) antigens and beta-2 microglobulins in, 3024 chemotherapy for, physician nonadherence to, 945
Bleeding complications, in essential thrombocythemia, 2926 copper in, 738
Bleomycin ductal in situ
in cervical cancer, with radical surgery, 372 conservative surgery and radiotherapy for, 7
fractionated cobalt 57-labeled, in vivo measurement of, 2477 with microinvasion, surgery only for, 1498
in head and neck cancer, with radiotherapy, 915 early, follow-up care in, 55
in lymphoma, in elderly, 1487 in eideiy, treatment and survivai in, 2227
Blood cells, control of growth and differentiation in, 2684 epidemiology of, in U.S. vs. Japan, 746
Blood count, in early breast cancer follow-up, 55 etoposide for, 266
Blood group antigens hormone receptors in, 463
in esophageal carcinoma, 3042 imaging of, for staging and follow-up, 1196
in oral squamous cell carcinoma, 613 intraductal, computerized image analysis of, 2805
in transitional cell carcinoma of bladder, 3024, 1661 Ki-67 immunostaining in, 463
Blue nevus, malignant, 2653 lumpectomy without radiation for, recurrence after, 2079
No. 12 SUBJECT INDEX—-VOLUME 67
mammographically detected, treatment results in, 2801 early detection of, behavioral research in, 800
mammographic densities and, 2833 epidemiology of, in U.S. vs. Japan, 746
mammography for in Framingham heart study cohort, |
patient selection for, 2010 human costs of, 1716
screening, 1129 imaging of. See Imaging
cost/benefit analysis for, 1245 immuosuppressive acidic protein in, 610
meningeal carcinomatosis in, 1685 in mothers of childhood sarcoma patients, 1467
metatastic, outcome of in blacks vs. whites, 2850 occult, deep vein throinbosis and, 541
in mothers of childhood sarcoma patients, 1467 poorly differentiated of unknown primary site, etoposide for,
node-negative 310
adjuvant therapy for, prognostic factors in patient selection prepaid delivery system for, 1767
for, 1741 prevention of
chemotherapy for, 1744 demographic factors in, 1814
nucleolar organizer region—associated proteins in, 463 inner city clinic for, 1802
oncogene amplification in, 1396 lifestyle modification and health promotion for
peanut lectin binding in, 463 assessment of, 805
phosphate metabolites and hormone receptors in, 2919 epidemiologic perspectives on, 808
physical examination screening for, in Japan, 2021 psychosocial and behavioral research in, 767, 800, 813, 833,
Pneumocystis carinii pneumonia in, 2407 860, 865
pregnancy-associated, prognosis in, 869 school health education for, 1828
progesterone receptors in psychoneuroimmunology and, 813
DNA synthesis arrest and, 1352 psychosocial and behavioral research in, 767
immunohistochemical evaluation of, 455 enabling strategies for, 860
proliferation and DNA ploidy in, early oral contraceptive use future priorities for, 865
and early abortions and, 1285 psychosocial research in, in children, 833
psychosocial adjustment in, 1097 screening for. See Screening
risk of, mammographic densities and, 2833 social environment and social support in, 788, 794
screening for, in Japan, 2021 Cancer care
serum melatonin depression in, 1681 access to, 1736
soluble histocompatibiltiy antigen class I in, tumor burden economic factors in, 1718, 1728, 1732, 1736, 17468, 1750,
and, 2295 1814
tamoxifen with and without fluoxymesterone in, 886 advances in, costs of, 1718
thermography in, prognosis and, 1678 alternative therapies in, 1788, 2225
tumor heterogeneity in, flow cytometric determination of, cessation of, in advanced disease, 1817
1401 clinical trials for. See Clinical trials
tumor markers in, 463 continuity of, 1759
zinc in, 738 cost containment measures for, 1718, 1728
Breast lesions, occult, scouting needle aspiration of, 2150 demographic changes and, 1728, 1772
Breast lymphoma, 1359 legislative influences on, 1732
Breast-ovarian cancer, familial, 1460 palliative, 1817
Breast tumors patient perceptions of, 1783
benign vs. malignant, phosphate metabolites and hormone psychosocial and behavioral research in, 767, 813, 833, 860,
receptors in, 2919 865
Ki-67 immunostaining in, prognosis and, 421 quality assurance in, 1800
syringomatous squamous, 2350 quality of, measurement of, 1753
Bromodeoxyuridine-labeling indices, in adult cerebral astrocytic rationing of, 1718, 1728, 1814
tumors, prognosis and, 1629 Carboplatin
Bronchial carcinoid, growth hormone-releasing hormone in, in brain stem glioma, 43
2538 in esophageal squamous cell carcinoma, 354
Bronchioloalveolar adenocarcinoma, with myoepithelial cells, in small cell lung cancer, 2980
2356 Carcinoembryonic antigen
Bronchogenic carcinoma. See Lung, carcinoma of in early breast cancer follow-up, 55
Bronchoscopy, fiberoptic, for lung tumor biopsy, 72 in gastric adenocarcinoma cells, radiation effects on, 2269
Bronchus, cancerous and precancerous lesions of, nucleolar or- Carcinogenesis, foreign body (editorial), 2731
ganizer regions in, 472 Carcinoid tumors
Brush biopsy, of lung tumors, fiberoptic bronchoscopy for, 72 bronchial, growth hormone-releasing hormone in, 2538
cyproheptadine for, 33
€ gastric, precursor lesions of, 663
interferon for, 547
CA 125, in non-small cell lung cancer, 150 Cardiac rhabdomyosarcoma, magnetic resonance imaging of,
Calcaneal metastasis, isolated, in endometrial adenocarcinoma, 2066
1979 Cardiomyopathy, doxorubicin, in Wilms’ tumor survivors, 331
Cancer beta-Carotene, cellular immunity and, 1556
advanced, cessation of treatment in, 1817 Catheter, Hickman, interpericardial 5-fluorouracil infusion via,
data assessmeni for, 780 735
3170 CANCER June 15 1991
Cauda equina compression, from metastziic melanoma, pallia- in brain stem glioma, 43
tive radiotherapy for, 2472 in breast cancer, 260
CD34 antigen, in Philadelphia chromosome-positive acute with hormonal therapy, 886
lymphoblastic leukemia, 1565 with node-negative disease, 1741, 1744
Cellular immunity, 13-cis-retinoic acid and beta carotene and, physician nonadherence to, 945
1556 Pneumocystis carinii pneumonia and, 2407
Central nervous system lymphoma weight gain with, 1954
in AIDS, 2756 in canine ostzosarcoma, response to, percent tumor necrosis
Epstein-Barr virus in, in situ hybridization for, 434 and, 126
after Hodgkin’s disease, 440 in carcinoid tumor and malignant carcinoid syndrome, 33
as second malignancy, 1431 in cervical cancer
Central nervous system tumors interferon system and, 87
in children, imaging of, 1223 with radical surgery, 372
embryonal neuroepithelial, differentiation in, 965 in childhood cancer, osteosarcoma after, 193
c-erbB2/neu expression, in head and neck tumors and breast clinical trials of. See Clinical trials
cancer, 2142 in colorectal carcinoma, 14, 1294
c-erbB-2 oncoprotein, in gastric carcinoma, prognosis and, 2914 in ectopic adrenocorticotropic hormone syndrome, 1447
Cerebellar astrocytoma, histologic condition and treatment of, in esophageal carcinoma, with radiotherapy, 2258
in children, 2772 in esophageal squamous cell carcinoma, 354
Cerebral astrocytoma, high-grade, accelerated fractionation for, in gastric carcinoma, 260, 2454
2247 in germ cell tumors, 20
Cerebral lymphoma. See Central nervous system lymphoma for salvage, 1305
Cerebral metastases in head and neck cancer, with radiotherapy, 915
as first symptom in bronchogenic carcinoma, 2935 in hepatocellular carcinoma, transcatheter arterial emboli-
from ovarian carcinoma, 2194 zation and arterial infusion in, prognostic factors for,
Cerebral tumors. See Brain, tumors of 385
Cervix in Hodgkin’s disease, 271
carcinoma of in idiopathic hypereosinophilic syndrome, 2826
argyrophil small cell, cell line from integrating HPV16 intracarotid, in brain tumors, 2844
DNA, 2327 intraperitoneal, in advanced ovarian cancer, with radiother-
brachytherapy for, perioperative morbidity and mortality apy, 2867
with, 2786 intrathecal
chemotherapy aad radical surgery for, 372 in acute lymphocytic leukemia, hemiparesis and ischemia
imaging of, 1209 after, 2058
interferon system in, 87 acute tumor lysis syndrome after, 2062
prognostic factors in, 2776 in leukemia, 281, 285
radiotherapy for in lung cancer
lymphoctye subset distribution after, 2071 non-small cell, 2969, 2974, 250, 254, 892, 2439
second cancer after, 398 vs. symptomatic treatment, 2443
recurrent, iodine-125 interstitial implants in, 2467 with radiotherapy, 357
screening for, cost/benefit analysis for, 1245 small cell, 2980
clear cell adenocarcinoma of, 1971 in lymphoma
intraepithelial neoplasia of, acid-labile DNA measurement in, in elderly, 1487
3104 neuropathy and myopathy in, 2241
Langerhans cell histiocytosis of, 1650 in malignant pleural mesothelioma, 48
c-fms proto-oncogene, in gynecologic cancers, 990 in melanoma, 1514
Charles F. Kettering Prize, 2428 in Mevkel cell carcinoma, tumor lysis syndrome and, 2207
Charles S. Mott Prize, 2431, 2436 nausea and vomiting in
Chemoembolization, transcatheter arterial, in hepatocellular data assessment for, 780
carcinoma, 81, 385 physitilogic and psychobehavioral research in, 813
Chemotherapy. See also specific agents in neuroblastoma, 922
in acute leukemia, aortic arch occlusion by Aspergillus ana, in non-Hodgkin’s lymphoma, 271
3123 in orbital rhabdomyosarcoma, 560
in acute leukemia/lymphoma, in children, 1830 in osteosarcoma, acute lymphoblastic leukemia with t(4;11)
in acute lymphoblastic leukemia, “spread out” vs. “upfront,” translocation after, 2887
550 in Ovarian cancer, response to, cloning assay for, 20
in acute lymphoid leukemia, for first relapse, 37 in paranasal sinus and nasopharyngeal tumors, with radio-
in acute myleloid leukemia, in elderly, 1484 therapy, 2748
in acute nonlymphoblastic leukemia, 2235 physician nonadherence to, predictors of, 945
in adrenal cortical carcinoma, 2997 in pregnancy, 703
in adult Wilms’ tumor, 956 with radiotherapy, rationale for, 1471
in anal cancer, with radiotherapy, 2462 in recurrent pelvic desmoid tumor, 1443
in anaplastic giant cell thyroid carcinoma, 564 in renal cell carcinoma, 1509
in bone tumors, 1169 resistance to, in kidney tumors, circumvention of, 2484
No. 12 SUBJECT INDEX—VOLUME 67
in small cell carcinoma of vulva, 2415 in germ cell tumor, with etoposide, 28
in small cell lung cancer, 231, 245 in hepatocellular carcinoma, 896
in squamous cell carcinoma of skin, 2030 intracarotid, in brain tumors, 2844
in stage IV neuroblastoma, in infants, long-term survival and, intraperitoneal, in advanced ovarian cancer, with radiother-
1493 apy, 2867
in unresectable rectal cancer, with radictherapy, 2859 in lung cancer, with radiotherapy, 357
in urothelial cancer, response to, 1525 in malignant meosthelioma, of pleura, 48
in Wilms’ tumor ir. malignant mesothelioma, with doxorubicin, 2984
late effects of, 331 in metastatic melanoma, with dacarbazine, 1514
for relapse, 567 nephrotoxicity of, probenecid for, 1518
Chest radiography in non-small cell lung cancer, 892, 2439
for lung cancer screening, 1155 with 5-fluorouracil, 2969
for lung cancer staging, 1165 with interferon alpha-2B, 2448
Children. See also specific cancers of childhood; e.g., Leukemia; with novobiocin, 2969
Neuroblastoma vs. symptomatic treatment, 2443
acquired immunodeficiency syndrome in, disseminated leio- with vinblastine, 2969
myosarcoma in, 2618 in paranasal sinus and nasopharyngeal tumors, with radio-
adolescent therapy, 2748
differentiated thyroid cancer in, 2186 prolonged intra-arterial infusion of, increased tissue levels with,
synovial sarcoma in, 1667 2828
cancer survivor in small cell lung cancer, vs. etoposide, 245
achievment of life goals by, 206 in squamous cell carcinoma of skin, 2030
cancer in relatives of, 1467 in urothelial cancer, response to, 1525
cholelithiasis in, 1439 Clear cell adenocarcinoma, of vagina and cervix, 1971
central nervous system tumors in, imaging of, 1223 Clear cell carcinoma
cerebellar astrocytoma of, histologic condition and treatment of endometrium, with adenocarcinoma, cell lines from, 1588
of, 2772 of inguinal region, arising from endometriosis, 116
craniospinal irradiation in, for malignant intracranial epen- Clear cell sarcoma, of soft tissue, DNA content of, 2173
dymoma, 2766 Clinical trials
differentiated thyroid cancer in, 2186 access to and reimbursement for, 1750, 1779
infant family physician’s perspective on, 1798
brain stem glioma in, carboplatin for, 43 nurses’ expanding role in, 1793
stage IV neuroblastoma in, long-term survival in, 1493 participation in, economic factors in, 1750
osteosarcoma as second malignancy in, 193 Cloning assay, for chemotherapy response, in ovarian cancer,
psychosocial research in, 833 20
sarcoma survivor, cancer in relatives of, 1467 Clostridial bacteremia, in cancer patients, 1928
sun-induced freckles in, 1990 Colitis, ulcerative, extracolonic malignancies in, 2015
synovial sarcoma in, 1667 Collagen IV, in colorectal carcinoma, prognosis and, 99
very young, Hodgkin’s disease in, 1428 Colon carcinoma. See also Colorectal carcinoma
young, osteosarcoma in, 638 DNA in multiple tumor samples of, 106
Cholelithiasis epidemiology of, in U.S. vs. Japan, 746
after childhood cancer, 1439 hormone receptors in, 1964
colorectal carcinoma and, 1696 imaging of, 1150
Chondrosarcoma immune responses to tumor-associated antigens in lymph
magnetic resonance imaging and phosphorus spectroscopy of, nodes in, 2880
1849 node-positive, prognosis of, 1859
of synovium, 155 photoimmunodiagnosis of, antibody-fluorescein conjugates
Chronic leukemia. See Leukemia, chronic for, 2529
Chronic nonleukemic myeloproliferative disorders, life expec- protein tyrosine kinase levels in, 590
tancy in, 2658 ultrasound-guided hepatic cryosurgery in, 901
Cigarette smoking Colonoscopy, 1150
bladder cancer and, in Uruguay, 536 Colorectal carcinoma
pancreatic cancer and, 2664 collagen IV in, prognosis and, 99
tongue cancer and, in Uruguay, 1380 DNA ploidy and cellular atypia in, 1642
Cirrhosis, hepatocullular carcinoma in, thrombin- antithrombin DNA ploidy in, prognosis and, 1921
2776 complexes in, 481 5-fluorouracil and cisplatin for, 14
Cisplatin 5-fluorouracil for, 367
in adrenal cortical carcinoma, 2997 with cisplatin, 14, 1294
in anaplastic giant cell thyroid carcinoma, 564 gallstones and, 1696
in canine osteosarcoma, response to, percent tumor necrosis imaging of, 1181
and, 126 intraoperative electron beam radiotherapy for, 1504
in cervical cancer, with radical surgery, 372 natural history of, 1143
in colorectal carcinoma, 1294 recurrence of, DNA content and, 2599
with 5-fluorouracil, 14 Complete blood count, in early breast cancer follow- up, 55
3172 CANCER June 15 1991
Computed tomography. See also Imaging Daunorubicin
of adult primary gliomas, 1278 in acute leukemia, with etoposide, 285
advances in, 1121 in childhood cancer, osteosarcoma after, 193
of bone tumors, 1169 Deep venous thrombosis, occult cancer in, 541
of central nervous system tumors, in children, 1223 Demographic changes, health care issues and, 1728, 1772
cost/benefit analysis for, 1245 Depressed gastric adenoma, 2382
of gastrointestinal cancer, for staging and follow-up, 1181 Dermatcfibrosarcoma, magnetic resonance imaging and phos-
of gynecologic cancer, 1209 phorus spectroscopy of, 1849
of Hodgkin’s and non-Hodgkin’s lymphoma, 1177 Dermoid cyst, of ovary, melanoma in, 3141
of liver cancer, 1189 Desmoid tumor
of metastatic tumors of unknown origin, 1242 brachytherapy and surgery for, 380 ;
of parapharyngeal hemangiopericytoma, 61 magnetic resonance imaging and phosphorus spectroscopy of,
single photon emission, 1261, 1271 1849
Computerized image analysis recurrent pelvic, tamoxifen for, 1443
of intraductal breast cancer, 2805 Diagnosis, early, behavior research in, 800
of ovarian cancer, prognostic value of, 1318 Diagnostic imaging. See Imaging
Congenital angiotropic lymphoma of T-cell type, 2131 Diamine oxidase, post-heparin, in small intestinal lymphoma,
Congenital ocular melanoma, 2642 511
Copper, breast cancer and, 738 Diet, tongue cancer and, in Uruguay, 180
Corticosteroids, in lymphoma, neuropathy and myopathy in, Dietary modifications, recommendations for and implementa-
2241 tion of, 2671
Cost/benefit analysis Digestive cancer, sialyl Lewis A antigens in, 1576
for hematopoietic growth factors, 2727 Digital subtraction angiography, in parapharyngeal hemangio-
for imaging studies, 1245 pericytoma, 61
Cranial nerve palsy, in childhood acute lymphoblastic leukemia DNA, HPV16, argyrophil small cell carcinoma of cervix and,
and non-Hodgkin’s lymphoma, 2262 2327
Craniospinal irradiation, in malignant intracranial ependymoma, DNA alterations, somatic, in ovarian cancer, 1551
in children, 2766 DNA content
Crohn’s disease, extracolonic malignancies in, 2015 acid-labile, in cervical intraepithelial neoplasia, 3104
Cryosurgery, hepatic, ultrasound-guided, in hepatocellular car- of breast cancer
cinoma, 901 early oral contraceptive use and early abortions and, 1285
Cutaneous angiosarcoma, adrenal carcinoma simulating, 2766 for tumor heterogeneity determination, 1401
Cutaneous lymphoma of clear cell sarcoma of soft tissue, 2173
B-cell, 2311 of colon cancer, tumor sampling variability in, 106
13-cis-retinoic acid and, 2490 of colorectal cancer, 1642
Cyclocytidine, in acute lymphoblastic leukemia, 2235 prognosis and, 1921
Cyclophosphamide recurrence and, 2599
in acute lymphoid leukemia, for first relapse, 37 of esophageal carcinoma, recurrence time and, 1406
in lymphoma, in elderly, 1487 of esophageal squamous cell carcinoma, prognosis and, 2290
in malignant pleural mesothelioma, 48 of gastric carcinoma, prognosis and, 2588
Cyproheptadine, in carcinoid tumor and malignant carcinoid of hematogenous vs. lymphatic metastases, in lung adeno-
syndrome, 33 carcinoma, 2941
Cyst, ovarian dermoid, melanoma in, 3141 of hepatocellular carcinoma, 939
Cystadenocarcinoma, mucinous pancreatic, with pseudosar- of !aryngeal squamous cell carcinoma, 141
comatous mural nodules, 494 of lymph nodes, in lung cancer, prognosis and, 1370
Cystoprostatectomy, transurethral-resection zone prostate cancer of malignant pleural effusions, after intracavitary methyl-
detection by, 1418 prednisolone acetate, 3136
Cytogenetic heterogeneity, in benign neoplasm, 3110 of melanoma, metastasis and, 2333
Cytokines. See also Hematopoietic growth factors of metastatic soft tissue melanoma, 2173
biology of, transfusion medicine and, 2708 in multiple myeloma, 449
combination therapy with, 2718 of nonseminomatous germ cell tumors, 1874
Cytometry, DNA flow. See DNA content of ovarian carcinoma, prognosis and, 1878
Cytosine arabinoside of prostate cancer, prognosis and, 3014
in acute leukemia, with etoposide, 281, 285 DNA image cytometry, of esophageal squamous cell carcinoma,
in acute lymphoblastic leukemia, “spread out” vs. “upfront,” 2290
550 DNA synthesis, in breast cancer, arrest of with progesterone
in acute lymphoid leukemia, for first relapse, 37 receptor expression, 1352
DNA technology, in tumor gene identification (Charles S. Mott
D Prize), 2436
Dacarbazine, in metastatic melanoma, with cisplatin, 1514 Double-contrast barium enema, guidelines for, 1150
Dactinomycin Down’s syndrome, acute lymphocytic leukemia in, 1057
in mesothelioma, with tumor necrosis factor, 2495 Doxorubicin
single vs. fractionated, in Wilms’ tumor, 2990 in acute lymphoid leukemia, for first relapse, 27
Data assessment, for chemotherapy-induced nausea, 780 in adrenal cortical carcinoma, 2997
No. 12 SUBJECT INDEX—VOLUME 67 3173
in anaplastic giant cell thyroid carcinoma, 564 Epidermoid cancer, of head and neck, radical neck dissection
in childhood cancer, osteosarcoma after, 193 in, 67
in gastric cancer, with 5-fluorouracil, 2454 Epipodophyllotoxins, in acute lymphoblastic leukemia, hyper-
in lymphoma, in elderly, 1487 sensitivity to, 1070
in malignant mesothelioma Epitopes, tumor-associated antigen, in lymph nodes, in colon
with cisplatin, 2984 cancer, 2880
of pleura, 48
Epstein-Barr virus, in central nervous system lymphoma, in situ
resistance to, in renal carcinoma, trifluoperazine circumven-
hybridization for, 434
tion of, 2484
Esophageal carcinoma
in urothelial cancer, response to, 1525
adenoid cystic, 2159
in Wilms’ tumor, late effects of, 331
blood-group-related antigens in, 3042
Drainage, subxiphoid window, of pericardial effusion, vs. peri-
epidemiology of, in U.S. vs. Japan, 746
cardiectomy, 76
glutathione S-transferase-pi mRNA in, 2560
Dysgerminoma, ovarian, radiotherapy for, long-term effects of,
imaging of, for staging and follow-up, 1181
1084
radiotherapy with and without chemotherapy for, 2258
Dyspiastic nevus
recurrence time in, DNA ploidy and, 1406
melanocytic, clinical and histopathologic features of, 3157
17-beta estradiol growth inhibition of, 2284
sunlight and, 1701
squamous cell
carboplatin and vinblastine for, 354
E DNA image cytometry of, 2290
epidermal growth factor receptor in, 91
EAB902 mononoclonal antibody, in pleural mesothelioma dif- supraclavicular lymph node biopsy in, 585
ferentiation, 655 ultrasound staging in, 585
Economic factors Essential thrombocythemia
in cancer care. See under Cancer care life expectancy in, 2658
in hematopoietic growth factor therapy, 2727 thrombotic and hemorrhagic complications in, 2926
Ectopic adrenocorticotropic hormone syndrome, ketoconazole 17 beta-Estradiol, esophageal cancer growth inhibition by, 2284
for, 1447
Estrogen receptors
Education, school-based, for cancer prevention, 1828
in breast cancer, 463
Elderly
in breast tumors, 2919
acute myeloid leukemia in, 13-cis-retinoic acid for, 1484
in colon cancer, 1964
breast cancer in, treatment and survival in, 2227
in gastric cancer, localization of, 2401
increasing number of, health care costs and, 1728, 1772
in laryngeal tumors, 1347
poor-prognosis lymphoma in, brief combination chemother-
Estrone, breast cancer and, 2215
apy for, 1487
Etoposide
Embolization, transcatheter arterial, in hepatocellular carcinoma,
381, 385 in acute leukemia, 281, 285
Embryonal neuroepithelial tumors, of central nervous system, hypersensitivity to, 1070
in adult Wilms’ tumor, 956
differentiation in, 965
Endometriosis, clear cell carcinoma of inguinal region arising bone marrow transplantation and, 292
in breast cancer, 266
from, 116
Endometrium clinical pharmacology of, 319
adenocarcinoma of current and future status of, 215
with clear cell carcinoma, cell lines from, 1588 future directions for, 315
isolated calcaneal metastasis in, 1979 in germ cell tumor, with cisplatin, 28
in Norway, 3093 in Hodgkin’s and non-Hodgkin’s lymphoma, 271
carcinoma of in idiopathic hypereosinophilic syndrome, 2826
brachytherapy for, perioperative morbidity and mortality intracarotid, in brain tumors, 2844
with, 2786 in lymphoma, in elderly, 1487
in non-small cell lung cancer, 250, 254
imaging of, 1209
with cisplatin, 2439
macrophage colony-stimulating factor and receptor in, 990
radiotherapy for, 2872 oral
recurrent, iodine-125 interstitial implants in, 2467 chronic, 303, 315
tumor size in, prognosis and, 2791 vs. intravenous, pharmacology of, 299
Langerhans cell histiocytosis of, 1650 in ovarian cancer, 225
Endoscopic ultrasound, of gastrointestinal cancer, for staging in poorly differentiated carcinoma of unknown primary site,
and foiiow-up, 1181 310
Ependymoma, malignant intracranial, craniospinal irradiation in small cell lung cancer, 231
for, in children, 2766 vs. cisplatin, 245
Ephelides, in children and young adults, 1990 in testicular cancer, 220
Epidemiology, cancer, in U.S. vs. Japan, 746 Ewing’s sarcoma
Epidermal growth factor receptors histopathology of, prognosis and, 163
in laryngeal tumors, 1347 MIC2 antibodies in, 1886
in squamous cell carcinoma, 91 radiotherapy for, 2818
3174 CANCER June 15 1991
Excisional biopsy, vs. fine-needle aspiration biopsy, of lymph G
nodes, 1003
Experimental therapy. See Clinical trials Gallstones
Extracranial primitive neuroectodermal tumors, 1825 after childhood cancer, 1439
Extremity soft tissue sarcoma, reirradiation for, 2813 colorectal carcinoma and, 1696
Eye, congenital melanoma of, 2642 Ganglioside GM3:GD3 ratio, in melanoma, 3029
Gastric adenocarcinoma, carcinoembryonic antigen in, radiation
effects on, 2269
F Gastric adenoma, depressed, 2382
Gastric carcinoid, precursor lesions of, 663
Familial cancers, recessive mutations and (Charles S. Mott Prize), Gastric carcinoma
2431 c-erbB-2 oncoprotein in, prognosis and, 2914
Familial natural killer cell-T-lymphocyte proliferation disease, DNA —— of, prognosis and, 2588
2610 epidemioiogy of, in U.S. vs. Japan, 746
Familial ovarian cancer, 1460 estrogen receptor localization in, 2401
Fat, body distribution of, breast cancer and, 523, 2215, 2622 etoposide for, 260
'8F_2-deoxy-2-fluoro-D-glucose, uptake of in tumor xenografts, 5-fluorouracil and doxorubicin for, 2454
1544 idarubicin for, 2988
Ferritin, serum, gastric cancer risk and, 1707 imaging of, 1181
Fetal cellular rhabdomyoma, of tongue, vs. rhabdomyosarcoma, proliferative-associated nuclear antigen p105 in, 2523
2907 serum ferritin and, 1707
alpha-Fetoprotein splenectomy in, survivai and, 3006
from hepatoid adenocarcinoma of renal pelvis, 3051 weight loss in, 722
lectin binding by, in hepatocellular carcinoma, 476 Gastrointestinal pseudomalignant lesions of, bizarre stromal cells
in liver neoplasia differential diagnosis, 2390 in, 2111
Fiberoptic endoscopy, in nasopharyngeal cancer diagnosis, 3127 Gastrointestinal tumors, imaging of, 1181
Fibrin, vascular, in prostate cancer and hyperplasia, 1377 GD3:GM3 ratio, in melanoma, 3029
Fibroblastic/fibrohistiocytic proliferations, pyruvate kinase ac- Gender, and osteosarcoma incidence and survival, 2219
tivity and isozyme composition in, 2552 Gene mutations, recessive, in cancer etiology (Charles S. Mott
Fine-needle aspiration biopsy Prize), 2431
of bone tumors, 1169 General Motors Cancer Research Foundation Prizes, 2422, 2428,
in breast cancer, for oncogene analysis, 1396 2431, 2436
of cold thyroid nodules, 2137 Gene regulation (Alfred P. Sloan , Jr., Prize), 2422
of hepatocellular carcinoma, 673 Generic health outcomes, conceptualization and measurement
of lymph noues, vs. excisional biopsy, 1003 of, 774
of lymphoproliferative lesions, in HIV-positive patients, 1008 Genes, tumor, identification of with DNA technology (Charles
of occult breast lesions, with scouting needle, 2150 S. Mott Prize), 2436
in pancreatic duct stenosis, 2395
Gene transfer, into hematopoietic cells, 2700
ultrasound-guided, in esophageal carcinoma, 585
Genital tract, female. See also Gynecologic tumors
Flow cytometry
Langerhans cell histiocytosis of, 1650
DNA. See DNA content
Genotyping, of equivocal hematolymphoid lesions, 2890
RNA, in multiple myeloma, 449
Fludarabine, in hairy cell leukemia, 1291 Germ cell tumor(s)
beta-human chorionic gonadotropin-positive extragonadal,
5-Fluorouracil
of renal pelvis, 3146
in adrenal cortical carcinoma, 2997
etoposide and cisplatin for, 28
in anal cancer, with radiotherapy, 2462
nonseminomatous
in colorectal carcinoma, 367, 1294
DNA ploidy in, 1874
with and without cisplatin, 14
in gastric cancer, with doxorubicin, 2454 extragonadal and poor risk, prognostic factors in, 2049
salvage therapy for, 1305
intrapericardial infusion of, 735
tumor markers in, risk assignment and, 1299
in malignant pleural mesothelioma, 48
in non-small cell lung cancer, 2974, 892 Glioblastoma, adult, bromodeoxyuridine-labeling indices and
with cisplatin, 2439 prognosis in, 1629
in pancreatic adenocarcinoma, with N-(phosphonacetyl)-L- Glioma
aspartate, 363 adult primary, imaging of, 1278
in squamous cell carcinoma of skin, 2030 brain stern, carboplatin for, 43
in unresectable rectal cancer, with leucovorin and radiother- radiation-induced, 392
apy, 2859 Gliosarcoma, clinicopathology of, 2342
Fluoxymesterone, in breast cancer, with tamoxifen, 886 Glottic carcinoma, radiotherapy for, recurrence after, 577
Forceps biopsy, of lung tumors, fiberoptic bronchoscopy for, 72 Glutathione S-transferase-pi mRNA, in esophageal carcinoma,
Foreign body carcinogenesis (editorial), 2731 2560
Framingham heart study cohort, cancer experience in, | Glutathione S-transferases, alpha, mu, and pi classes of, im-
Freckles, sun-induced, in children and young adults, 1990 munohistologic localization of, 1608